UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 76

Sortiert nach

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial

Nature medicine, 2021-12, Vol.27 (12), p.2192-2199

2021

Volltextzugriff (PDF)

Polycythemia vera and essential thrombocythemia of intermediate-age: A real-life, multicenter analysis of first-line treatment approach

Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2024-04, Vol.34 (1)

2024

Volltextzugriff (PDF)

Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations

Thrombosis research, 2019-10, Vol.182, p.133-140

2019

Volltextzugriff (PDF)

Acquired von Willebrand Syndrome

Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2016-11, Vol.25 (6), p.1337-1344

Mital, Andrzej

2016

Volltextzugriff (PDF)

Real-World Efficacy of Midostaurin in Aggressive Systemic Mastocytosis

Journal of clinical medicine, 2021-03, Vol.10 (5), p.1109

2021

Volltextzugriff (PDF)

Acquired von Willebrand Syndrome During the Course of Myelofibrosis: Analysis of 32 Cases

Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2015, Vol.24 (6), p.1001-1006

2015

Volltextzugriff (PDF)

Diagnostics and treatment of prolonged menstrual bleedings in girls with von Willebrand disease

Journal of Transfusion Medicine, 2021-12, Vol.14 (4), p.238-241

2021

Volltextzugriff (PDF)

Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

The New England journal of medicine, 2023-01, Vol.388 (4), p.319-332

2023

Volltextzugriff (PDF)

Haemate P − zastosowanie w profilaktyce i leczeniu krwawień w chorobie von Willebranda oraz indukcji immunotolerancji w hemofilii A powikłanej inhibitorem

Acta haematologica polonica, 2017-04, Vol.48 (2), p.125-129

Mital, Andrzej

2017

Volltextzugriff (PDF)

Haemate P − zastosowanie w profilaktyce i leczeniu krwawień w chorobie von Willebranda oraz indukcji immunotolerancji w hemofilii A powikłanej inhibitorem

Acta haematologica polonica, 2017-04, Vol.48 (2), p.125-129

Mital, Andrzej

2017

Volltextzugriff (PDF)

Strength training program for an athlete with hemophilia A and an inhibitor while taking a new prophylactic drug treatment: a case report

Physiotherapy theory and practice, 2023-11, Vol.39 (11), p.1-2478

2023

Volltextzugriff (PDF)

Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial

Journal of clinical oncology, 2023-02, Vol.41 (5), p.1035-1045

2023

Volltextzugriff (PDF)

Zanubrutinib: a novel therapeutic option for the treatment of B-cell neoplasms

Acta haematologica polonica, 2023-04

2023

Volltextzugriff (PDF)

Acquired von Willebrand syndrome during systemic mastocytosis: an analysis of 21 cases

Polskie archiwum medycyny wewne̦trznej, 2018-08, Vol.128 (7-8), p.491-493

2018

Volltextzugriff (PDF)

Marginal zone B-cell lymphoma with multiple extranodal locations in a patient with Sjögren’s syndrome – a diagnostic problem

Reumatologia, 2014-09, Vol.52 (4), p.276-281

2014

Volltextzugriff (PDF)

COVID-19 - Toward a comprehensive understanding of the disease

Cardiology journal, 2020-05, Vol.27 (2), p.99-114

2020

Volltextzugriff (PDF)

A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia

British journal of haematology, 2023-01, Vol.200 (2), p.229-239

2023

Volltextzugriff (PDF)

Prevalence of acquired von Willebrand syndrome during essential thrombocythemia: a retrospective analysis of 170 consecutive patients

Polskie archiwum medycyny wewne̦trznej, 2015-01, Vol.125 (12), p.914-920

2015

Volltextzugriff (PDF)

Preparation of patients with mastocytosis and mast cell activation syndrome for surgery, childbirth, and radiological examinations

Alergologia Polska - Polish Journal of Allergology, 2023-10, Vol.10 (4), p.301-309

2023

Volltextzugriff (PDF)

Factors predisposing to acquired von Willebrand syndrome during the course of polycythemia vera – retrospective analysis of 142 consecutive cases

Thrombosis research, 2015-10, Vol.136 (4), p.754-757

2015

Volltextzugriff (PDF)

Excessive amount and activity of μ-calpain affects apoptotic machinery in chronic B-cell leukemia cells and influences the course of the disease

Acta biochimica Polonica, 2020-06, Vol.67 (2), p.247

2020

Volltextzugriff (PDF)

Acquired von Willebrand Syndrome During the Course of Myelofibrosis: Analysis of 32 Cases

Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2015-11, Vol.24 (6), p.1001-1006

2015

Volltextzugriff (PDF)

Acquired von Willebrand syndrome during the course of systemic mastocytosis – analysis of 21 cases

Polskie archiwum medycyny wewne̦trznej, 2018-07

2018

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(73)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(36)
Humans
(32)
Male
(18)
Female
(17)
Middle Aged
(17)
Hematology
(15)
Adult
(14)
Aged
(13)
Aged, 80 And Over
(8)
General & Internal Medicine
(8)
Medicine, General & Internal
(8)
Retrospective Studies
(7)
Medicine, Research & Experimental
(6)
Oncology
(6)
Research & Experimental Medicine
(6)
Treatment Outcome
(6)
Cardiovascular System & Cardiology
(5)
Leukemia
(5)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial

Polycythemia vera and essential thrombocythemia of intermediate-age: A real-life, multicenter analysis of first-line treatment approach

Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations

Acquired von Willebrand Syndrome

Real-World Efficacy of Midostaurin in Aggressive Systemic Mastocytosis

P1023: AVAPRITINIB IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM): EFFICACY AND SAFETY ANALYSES FROM THE PHASE 2 PATHFINDER STUDY WITH 2‐YEAR FOLLOW‐UP

Acquired von Willebrand Syndrome During the Course of Myelofibrosis: Analysis of 32 Cases

Diagnostics and treatment of prolonged menstrual bleedings in girls with von Willebrand disease

Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

Haemate P − zastosowanie w profilaktyce i leczeniu krwawień w chorobie von Willebranda oraz indukcji immunotolerancji w hemofilii A powikłanej inhibitorem

Haemate P − zastosowanie w profilaktyce i leczeniu krwawień w chorobie von Willebranda oraz indukcji immunotolerancji w hemofilii A powikłanej inhibitorem

Strength training program for an athlete with hemophilia A and an inhibitor while taking a new prophylactic drug treatment: a case report

Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial

Zanubrutinib: a novel therapeutic option for the treatment of B-cell neoplasms

Acquired von Willebrand syndrome during systemic mastocytosis: an analysis of 21 cases

Marginal zone B-cell lymphoma with multiple extranodal locations in a patient with Sjögren’s syndrome – a diagnostic problem

COVID-19 - Toward a comprehensive understanding of the disease

A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia

Prevalence of acquired von Willebrand syndrome during essential thrombocythemia: a retrospective analysis of 170 consecutive patients

Preparation of patients with mastocytosis and mast cell activation syndrome for surgery, childbirth, and radiological examinations

Factors predisposing to acquired von Willebrand syndrome during the course of polycythemia vera – retrospective analysis of 142 consecutive cases

Excessive amount and activity of μ-calpain affects apoptotic machinery in chronic B-cell leukemia cells and influences the course of the disease

Acquired von Willebrand Syndrome During the Course of Myelofibrosis: Analysis of 32 Cases

Acquired von Willebrand syndrome during the course of systemic mastocytosis – analysis of 21 cases

Zanubrutinib Demonstrates Superior Progression-Free Survival (PFS) Compared with Ibrutinib for Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (R/R CLL/SLL): Results from Final Analysis of ALPINE Randomized Phase 3 Study

Suchergebnisse filtern